ZyCoV-D
Emergency approval for Zydus Cadila to take few more days, say sources
ZyCoV-D is a DNA Covid vaccine, which carries the genetic code for that part of a virus that triggers the immune system of the body
Bharat Biotech’s Covaxin shows ‘encouraging results’ in phase-I of human trials
Covaxin is one of the only two indigenous COVID vaccine candidates approved for human clinical trials in India
2 of 2